245 related articles for article (PubMed ID: 8818850)
21. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women.
Masterton RG; Bochsler JA
J Antimicrob Chemother; 1995 Jan; 35(1):129-37. PubMed ID: 7768760
[TBL] [Abstract][Full Text] [Related]
22. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
23. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
De Abate CA; Perrotta RJ; Dennington ML; Ziering RM
J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
Beghi G; Berni F; Carratù L; Casalini A; Consigli G; D'Antò M; Gioia V; Molino A; Paizis G; Vaghi A
J Chemother; 1995 Apr; 7(2):146-52. PubMed ID: 7666122
[TBL] [Abstract][Full Text] [Related]
25. A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.
Rademaker CM; Sips AP; Beumer HM; Hoepelman IM; Overbeek BP; Möllers MJ; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():75-81. PubMed ID: 2286595
[TBL] [Abstract][Full Text] [Related]
26. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
[TBL] [Abstract][Full Text] [Related]
27. [The clinical and economic efficacies of short courses of azithromycin in acute sinusitis].
Karpov OI
Antibiot Khimioter; 1999; 44(10):28-32. PubMed ID: 10635419
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin for acute lower respiratory tract infections.
Panpanich R; Lerttrakarnnon P; Laopaiboon M
Cochrane Database Syst Rev; 2008 Jan; (1):CD001954. PubMed ID: 18253999
[TBL] [Abstract][Full Text] [Related]
29. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
30. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
31. Open randomized study comparing doxycycline and co-amoxiclav in the treatment of acute suppurative tracheobronchitis in adults. The Collaborative Group of the Centre Universitaire de Medécine Générale de L'Université Libre de Bruxelles (CUMG-ULB) Investigators.
Sternon J
J Int Med Res; 1995; 23(5):369-76. PubMed ID: 8529780
[TBL] [Abstract][Full Text] [Related]
32. Azithromycin for acute lower respiratory tract infections.
Laopaiboon M; Panpanich R; Swa Mya K
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001954. PubMed ID: 25749735
[TBL] [Abstract][Full Text] [Related]
33. Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia.
Lode H; Magyar P; Muir JF; Loos U; Kleutgens K;
Clin Microbiol Infect; 2004 Jun; 10(6):512-20. PubMed ID: 15191378
[TBL] [Abstract][Full Text] [Related]
34. Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
Daniel RR
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():65-71. PubMed ID: 8396099
[TBL] [Abstract][Full Text] [Related]
35. Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis.
Klapan I; Culig J; Oresković K; Matrapazovski M; Radosević S
Am J Otolaryngol; 1999; 20(1):7-11. PubMed ID: 9950107
[TBL] [Abstract][Full Text] [Related]
36. Azithromycin. A review of its use in paediatric infectious diseases.
Langtry HD; Balfour JA
Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
[TBL] [Abstract][Full Text] [Related]
37. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis.
Henry DC; Riffer E; Sokol WN; Chaudry NI; Swanson RN
Antimicrob Agents Chemother; 2003 Sep; 47(9):2770-4. PubMed ID: 12936972
[TBL] [Abstract][Full Text] [Related]
38. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.
Arrieta A; Arguedas A; Fernandez P; Block SL; Emperanza P; Vargas SL; Erhardt WA; de Caprariis PJ; Rothermel CD
Antimicrob Agents Chemother; 2003 Oct; 47(10):3179-86. PubMed ID: 14506028
[TBL] [Abstract][Full Text] [Related]
39. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
Gooch WM; Blair E; Puopolo A; Paster RZ; Schwartz RH; Miller HC; Smyre HL; Yetman R; Giguere GG; Collins JJ
Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
